Starpharma Holdings Ltd (SPL.AX)
-ASX 0.87 
0.02(1.70%) 23 May 16:10
| Prev Close: | 0.88 |
|---|
| Open: | 0.88 |
|---|
| Bid: | 0.85 |
|---|
| Ask: | 0.90 |
|---|
| 1y Target Est: | 1.79 |
|---|
| Beta: | N/A |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | 0.86 - 0.88 |
|---|
| 52wk Range: | 0.83 - 1.75 |
|---|
| Volume: | 586,682 |
|---|
| Avg Vol (3m): | 474,482 |
|---|
| Market Cap: | 245.35M |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | N/A |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in AUD.
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | 83.56 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Jun-13)
: | -0.04 |
|---|
| Quarterly EPS Est
(0-00-31)
: | N/A |
|---|
| Mean Recommendation*: | 1.7 |
|---|
| PEG Ratio (5 yr expected): | N/A |
|---|
Business Summary
Starpharma Holdings Limited, together with its subsidiaries, engages in the development and commercialization of dendrimer products for pharmaceutical, life science, and other applications primarily in the United States and Australia.
View More